Table 2 Assessment of clinicopathological parameters predicting progression-free survival on univariate and multivariate analyses

Age

60</≤60

11/50

0.4890 (0.105–2.289)

0.3632

FIGO class

III, IV/I, II

10/51

30.303 (7.353–125)

< 0.0001

19.608 (5.952–66.667)

< 0.0001

Blood marker

Positive/negative

48/13

0.806 (0.204–3.185)

0.7583

Histology

Clear cell/endometrioid

41/20

2.212 (0.5778–8.475)

0.2463

Standard treatment

Incomplete/complete

8/53

6.410 (1.488–27.778)

0.0126

7.576 (1.828–31.25)

0.0052

SOD2 expression

High/low

46/15

17.543 (1.825–166.667)

0.0130

10 (1.271–76.923)

0.0287